JWBC
IBB icon

J.W. Burns & Co’s iShares Biotechnology ETF IBB Stock Holding History

J.W. Burns & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Sell
10,973
-261
-2% -$44.9K 0.22% 72
2026
Q1 		$1.9M Sell
11,234
-730
-6% -$125K 0.22% 74
2025
Q4 		$2.02M Sell
11,964
-15
-0.1% -$2.44K 0.22% 68
2025
Q3 		$1.73M Sell
11,979
-1,858
-13% -$254K 0.2% 80
2025
Q2 		$1.75M Sell
13,837
-3,745
-21% -$460K 0.21% 79
2025
Q1 		$2.25M Sell
17,582
-1,937
-10% -$263K 0.29% 67
2024
Q4 		$2.58M Sell
19,519
-129
-0.7% -$18.1K 0.33% 59
2024
Q3 		$2.86M Sell
19,648
-260
-1% -$37.6K 0.37% 57
2024
Q2 		$2.73M Sell
19,908
-533
-3% -$71.2K 0.37% 59
2024
Q1 		$2.8M Sell
20,441
-2,260
-10% -$309K 0.39% 58
2023
Q4 		$3.08M Sell
22,701
-256
-1% -$31.2K 0.46% 53
2023
Q3 		$2.81M Sell
22,957
-75
-0.3% -$9.54K 0.45% 55
2023
Q2 		$2.92M Sell
23,032
-870
-4% -$113K 0.47% 54
2023
Q1 		$3.09M Sell
23,902
-76
-0.3% -$9.95K 0.53% 54
2022
Q4 		$3.15M Sell
23,978
-754
-3% -$97.4K 0.57% 51
2022
Q3 		$2.89M Sell
24,732
-1,668
-6% -$207K 0.57% 52
2022
Q2 		$3.1M Sell
26,400
-2,237
-8% -$266K 0.59% 50
2022
Q1 		$3.73M Sell
28,637
-1,411
-5% -$184K 0.59% 50
2021
Q4 		$4.59M Buy
30,048
+933
+3% +$144K 0.66% 45
2021
Q3 		$4.71M Buy
29,115
+850
+3% +$143K 0.74% 41
2021
Q2 		$4.63M Buy
28,265
+1,772
+7% +$273K 0.73% 42
2021
Q1 		$3.99M Sell
26,493
-11
-0% -$1.75K 0.67% 46
2020
Q4 		$4.01M Buy
26,504
+355
+1% +$50.7K 0.71% 42
2020
Q3 		$3.54M Buy
26,149
+40
+0.2% +$5.43K 0.71% 43
2020
Q2 		$3.57M Sell
26,109
-156
-0.6% -$19.9K 0.79% 38
2020
Q1 		$2.83M Sell
26,265
-300
-1% -$34.5K 0.76% 41
2019
Q4 		$3.2M Sell
26,565
-375
-1% -$41.8K 0.68% 48
2019
Q3 		$2.68M Sell
26,940
-197
-0.7% -$20.6K 0.62% 53
2019
Q2 		$2.96M Buy
27,137
+1,452
+6% +$154K 0.69% 48
2019
Q1 		$2.87M Buy
25,685
+25
+0.1% +$2.74K 0.7% 51
2018
Q4 		$2.47M Sell
25,660
-528
-2% -$56K 0.69% 48
2018
Q3 		$3.19M Sell
26,188
-745
-3% -$87.7K 0.75% 45
2018
Q2 		$2.96M Buy
26,933
+95
+0.4% +$10.2K 0.75% 46
2018
Q1 		$2.87M Sell
26,838
-235
-0.9% -$26K 0.74% 49
2017
Q4 		$2.89M Sell
27,073
-1,205
-4% -$129K 0.73% 46
2017
Q3 		$3.14M Sell
28,278
-360
-1% -$38.5K 0.84% 43
2017
Q2 		$2.96M Sell
28,638
-159
-0.6% -$15.7K 0.8% 44
2017
Q1 		$2.81M Buy
28,797
+90
+0.3% +$8.62K 0.78% 45
2016
Q4 		$2.54M Buy
28,707
+480
+2% +$43.7K 0.74% 49
2016
Q3 		$2.72M Hold
28,227
– – 0.84% 39
2016
Q2 		$2.42M Buy
28,227
+840
+3% +$75.4K 0.74% 46
2016
Q1 		$2.38M Sell
27,387
-22,368
-45% -$2M 0.76% 46
2015
Q4 		$5.61M Sell
49,755
-1,278
-3% -$139K 1.78% 13
2015
Q3 		$5.16M Sell
51,033
-2,202
-4% -$264K 1.77% 14
2015
Q2 		$6.55M Sell
53,235
-870
-2% -$104K 2.14% 11
2015
Q1 		$6.19M Sell
54,105
-768
-1% -$84.7K 2.03% 11
2014
Q4 		$5.55M Sell
54,873
-771
-1% -$74.9K 1.83% 12
2014
Q3 		$5.08M Sell
55,644
-825
-1% -$72.4K 1.71% 15
2014
Q2 		$4.84M Sell
56,469
-2,250
-4% -$177K 1.61% 17
2014
Q1 		$4.63M Sell
58,719
-150
-0.3% -$12.5K 1.64% 17
2013
Q4 		$4.46M Sell
58,869
-600
-1% -$42.6K 1.55% 19
2013
Q3 		$4.16M Sell
59,469
-210
-0.4% -$13.8K 1.59% 17
2013
Q2 		$3.46M Buy
+59,679
New +$3.45M 1.42% 17

Other funds holding IBB

GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SCA
Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

J.W. Burns & Co's IBB Position: Q2 2026 in Review

J.W. Burns & Co reduced its iShares Biotechnology ETF (IBB) stake by 2.3% in Q2 2026, selling an estimated $44.9K and leaving 10,973 shares worth $2.09M. The position accounts for 0.22% of the portfolio, ranked #72.

J.W. Burns & Co first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.55M in Q2 2015. 158 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • J.W. Burns & Co held 10,973 shares of iShares Biotechnology ETF worth $2.09M as of Q2 2026.
  • J.W. Burns & Co sold 261 iShares Biotechnology ETF shares in Q2 2026, an estimated $44.9K.
  • iShares Biotechnology ETF made up 0.22% of J.W. Burns & Co's portfolio in Q2 2026, its #72 holding.
  • J.W. Burns & Co first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • J.W. Burns & Co's iShares Biotechnology ETF position peaked at $6.55M in Q2 2015.
  • 158 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on J.W. Burns & Co's 13F filing for Q2 2026, filed 15 Jul 2026.